Concepedia

Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis

Johannan F. Brandse, Gijs R. van den Brink, Manon E. Wildenberg, Desirée van der Kleij, Theo Rispens, Jeroen M. Jansen, Ron A. A. Mathôt, Cyriel Y. Ponsioen, Mark Löwenberg, Geert D’Haens

Gastroenterology · 2015 · 421 citations · 25 references

DOI

Concepts

References

25

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.2K citations

, , +12

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text

, , +14

Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis

Kenneth W. Schroeder, William J. Tremaine, Duane M. Ilstrup · New England Journal of Medicine · 1987 · 3K citations

, , +14

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

Filip Baert, Maja Noman, Séverine Vermeire et al. · New England Journal of Medicine · 2003 · 2K citations · Full text

, , +17

Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor

Erik‐Oliver Glocker, Daniel Kotlarz, Kaan Boztuǧ et al. · New England Journal of Medicine · 2009 · 1.4K citations · Full text

, , +17